U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
APVO-436
Preferred Name English
Mipletamig
INN  
Official Name English
ANTI-CD123/CD3 BISPECIFIC ANTIBODY APVO436
Common Name English
IG chainscFvkh-G1hCH2CH3-scFvhk Homo sapiens and humanized (1-757) [scFvkh anti-IL3RA Homo sapiens (1-259) [V-KAPPA (Homo sapiens IGKV4-1*01 (99.0%) -IGKJ4*01 (100%), CDR-IMGT [12.3.10] (27-38.56-58.95-104)) (1-114) -20-mer tetrakis(tetraglycyl-seryl) li
Common Name English
Immunoglobulin, anti-(human interleukin 3 receptor) (human-Mus musculus monoclonal APVO436 single-chain variable fragment VL-(GGGGS)4-VH) fusion protein with immunoglobulin G1 [5-serine,19-alanine,20-alanine,22-alanine,107-alanine,de-232-lysine] (human ?
Common Name English
mipletamig [INN]
Common Name English
immunoglobulin IG chain scFvkh-G1hCH2CH3-scFvhk dimer bisdisulfide, anti-[Homo sapiens IL3RA (interleukin 3 receptor subunit alpha, interleukin 3 receptor alpha (low affinity), CD123)] and anti-[Homo sapiens CD3E (CD3 epsilon, Leu-4)], Homo sapiens and h
Common Name English
APVO436
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 711019
Created by admin on Wed Apr 02 05:07:46 GMT 2025 , Edited by admin on Wed Apr 02 05:07:46 GMT 2025
Code System Code Type Description
FDA UNII
DNP8BBW84R
Created by admin on Wed Apr 02 05:07:46 GMT 2025 , Edited by admin on Wed Apr 02 05:07:46 GMT 2025
PRIMARY
CAS
2839556-21-5
Created by admin on Wed Apr 02 05:07:46 GMT 2025 , Edited by admin on Wed Apr 02 05:07:46 GMT 2025
PRIMARY
INN
12998
Created by admin on Wed Apr 02 05:07:46 GMT 2025 , Edited by admin on Wed Apr 02 05:07:46 GMT 2025
PRIMARY
NCI_THESAURUS
C157257
Created by admin on Wed Apr 02 05:07:46 GMT 2025 , Edited by admin on Wed Apr 02 05:07:46 GMT 2025
PRIMARY NCIT
SMS_ID
300000054779
Created by admin on Wed Apr 02 05:07:46 GMT 2025 , Edited by admin on Wed Apr 02 05:07:46 GMT 2025
PRIMARY
ACTIVE MOIETY
Mipletamig
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966